{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T10:46:07Z","timestamp":1649155567656},"reference-count":10,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,10,22]]},"DOI":"10.1182\/blood-2015-08-664052","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T16:08:07Z","timestamp":1445530087000},"page":"1975-1976","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["rVWF: treatment finally reaches the modern age"],"prefix":"10.1182","volume":"126","author":[{"given":"Ara D.","family":"Metjian","sequence":"first","affiliation":[{"name":"DUKE UNIVERSITY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"17","key":"2019111901424160800_B1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease.","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2019111901424160800_B2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/beha.2001.0136","article-title":"Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment.","volume":"14","author":"Rodeghiero","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"6","key":"2019111901424160800_B3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study.","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"issue":"2","key":"2019111901424160800_B4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"4","key":"2019111901424160800_B5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2516.2009.02025.x","article-title":"Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.","volume":"15","author":"Metjian","year":"2009","journal-title":"Haemophilia"},{"issue":"6","key":"2019111901424160800_B6","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"issue":"5","key":"2019111901424160800_B7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0049-3848(88)90328-3","article-title":"Venous thromboembolism and transient thrombocytopenia in a patient with diabetes insipidus treated with desmopressin acetate (DDAVP).","volume":"50","author":"Albert","year":"1988","journal-title":"Thromb Res"},{"issue":"2","key":"2019111901424160800_B8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJM198801143180215","article-title":"Myocardial infarction in a patient with hemophilia treated with DDAVP.","volume":"318","author":"Bond","year":"1988","journal-title":"N Engl J Med"},{"key":"2019111901424160800_B9","unstructured":"Humate-P prescribing information. http:\/\/labeling.cslbehring.com\/PI\/US\/Humate-P\/EN\/Humate-P-Prescribing-Information.pdf. Accessed August 17, 2015"},{"key":"2019111901424160800_B10","unstructured":"Alphanate prescribing information. http:\/\/www.alphanate.com\/documents\/234307\/234624\/Alphanate+PI_Nav_Footer\/ddecc393-94e6-43bc-aa92-9133b96dc960. Accessed August 17, 2015"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/17\/1975\/1389169\/1975.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/17\/1975\/1389169\/1975.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T01:43:03Z","timestamp":1574127783000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/17\/1975\/34418\/rVWF-treatment-finally-reaches-the-modern-age"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,22]]},"references-count":10,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015,10,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-08-664052","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,22]]}}}